ViroGates A/S - ESG Rating & Company Profile powered by AI
Scroll down to the bottom of the page for potential risks for ViroGates A/S based on sector, location and size. This analysis of ViroGates A/S employs data from across the internet and also from public disclosures by ViroGates A/S. The article contains a Q&A section for ViroGates A/S.
ViroGates A/S in the Biotechnology & Medical Research industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | ViroGates A/S | 8.0 | High |
| 1 | Analytik Jena AG | 8.0 | High |
| 1 | Adagio Therapeutics Inc | 8.0 | High |
| ... | ... | ... | |
| 233 | XLR Medical Corp | 0.0 | Low |
| 233 | rEVO Biologics Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ViroGates A/S have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes ViroGates A/S disclose current and historical energy intensity?
Sign up for free to unlockDoes ViroGates A/S report the average age of the workforce?
Sign up for free to unlockDoes ViroGates A/S reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes ViroGates A/S disclose its ethnicity pay gap?
Sign up for free to unlockDoes ViroGates A/S disclose cybersecurity risks?
Sign up for free to unlockDoes ViroGates A/S offer flexible work?
Sign up for free to unlockDoes ViroGates A/S have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes ViroGates A/S disclose the number of employees in R&D functions?
Sign up for free to unlockDoes ViroGates A/S conduct supply chain audits?
Sign up for free to unlockDoes ViroGates A/S disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes ViroGates A/S conduct 360 degree staff reviews?
Sign up for free to unlockDoes ViroGates A/S disclose the individual responsible for D&I?
Sign up for free to unlockDoes ViroGates A/S disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes ViroGates A/S disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes ViroGates A/S disclose water use targets?
Sign up for free to unlockDoes ViroGates A/S have careers partnerships with academic institutions?
Sign up for free to unlockDid ViroGates A/S have a product recall in the last two years?
Sign up for free to unlockDoes ViroGates A/S disclose incidents of discrimination?
Sign up for free to unlockDoes ViroGates A/S allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas ViroGates A/S issued a profit warning in the past 24 months?
Sign up for free to unlockDoes ViroGates A/S disclose parental leave metrics?
Sign up for free to unlockDoes ViroGates A/S disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes ViroGates A/S disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes ViroGates A/S disclose the pay ratio of women to men?
Sign up for free to unlockDoes ViroGates A/S support suppliers with sustainability related research and development?
Sign up for free to unlockDoes ViroGates A/S disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes ViroGates A/S reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs ViroGates A/S involved in embryonic stem cell research?
Sign up for free to unlockDoes ViroGates A/S disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes ViroGates A/S disclose its waste policy?
Sign up for free to unlockDoes ViroGates A/S report according to TCFD requirements?
Sign up for free to unlockDoes ViroGates A/S disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes ViroGates A/S disclose energy use targets?
Sign up for free to unlockDoes ViroGates A/S disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes ViroGates A/S have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for ViroGates A/S
These potential risks are based on the size, segment and geographies of the company.
ViroGates A/S, a medical technology company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.